• 1. Tuning the growth, crosslinking, and gating effect of disulfide-containing PGMAs on the surfaces of mesoporous silica nanoparticles for redox/pH dual-controlled cargo release
  Hang Zhou,Xin Wang,Jun Tang,Ying-Wei Yang Polym. Chem. 2016 7 2171
• 2. Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression
  Venkatesh Teja Banala,Sandeep Urandur,Shweta Sharma,Madhu Sharma,Ravi P. Shukla,Disha Marwaha,Shalini Gautam,Monika Dwivedi,Prabhat Ranjan Mishra Biomater. Sci. 2019 7 2889
• 3. Synthesis of crosslinkable diblock terpolymers PDPA-b-P(NMS-co-OEG) and preparation of shell-crosslinked pH/redox-dual responsive micelles as smart nanomaterials
  Jingjing Sun,Zhao Wang,Amin Cao,Ruilong Sheng RSC Adv. 2019 9 34535
• 4. Screening and electrochemical detection of an antibiotic producing gene in bacteria on an integrated microchip
  Dawoon Han,Rohit Chand,Ik-Soo Shin,Yong-Sang Kim Anal. Methods 2013 5 6814
• 5. Fluorescent analogs of the marine natural product psammaplin A: synthesis and biological activity
  Fabia Hentschel,Florenz Sasse,Thomas Lindel Org. Biomol. Chem. 2012 10 7120

• Solvents and Organic Chemicals Organic Compounds Organosulfur compounds Organic disulfides Dialkyldisulfides

Ethanamine, 2,2'-dithiobis-, hydrochloride (1:1): A Versatile Compound in Modern Biomedical Applications

Ethanamine, 2,2'-dithiobis-, hydrochloride (1:1) is a sulfur-containing organic compound with the chemical formula C₄H₁₀N₂S₂Cl₂. This molecule, characterized by its unique CAS No. 1072-22-6, serves as a critical intermediate in the synthesis of various bioactive agents. Its structural features, including two sulfur atoms bridging two ethylamine groups, enable it to participate in diverse chemical reactions that are pivotal for drug development and material science. Recent advancements in biotechnology have further highlighted its potential as a multifunctional scaffold for designing novel therapeutics.

The molecular architecture of Ethanamine, 2,2'-dithiobis-, hydrochloride (1:1) is defined by the presence of disulfide bonds, which confer unique redox properties. These bonds are known to modulate biological activity by interacting with thioredoxin systems and glutathione-dependent pathways. A 2023 study published in Journal of Medicinal Chemistry demonstrated that the disulfide linkage in this compound can act as a "chemical switch" for controlled drug release in targeted delivery systems. This property is particularly relevant in the context of cancer therapy, where precise spatial and temporal control over drug release is critical for minimizing systemic toxicity.

In the realm of polymer science, Ethanamine, 2,2'-dithiobis-, hydrochloride (1:1) has emerged as a key component in the development of stimuli-responsive hydrogels. These materials are designed to undergo structural changes in response to environmental cues such as pH, temperature, or specific biochemical signals. A 2024 review in Biomaterials Science highlighted its role in creating smart hydrogels for tissue engineering applications. The compound's ability to form dynamic covalent networks through disulfide exchange reactions enables the creation of materials with tunable mechanical properties and degradation rates, which are essential for mimicking native extracellular matrices.

The pharmacological relevance of Ethanamine, 2,2'-dithi.

Recent advances in computational chemistry have provided new insights into the molecular interactions of Ethanamine, 2,2'-dithiobis-, hydrochloride (1:1). A 2023 study using molecular dynamics simulations revealed that the compound can form hydrogen bonds with specific amino acid residues in protein targets, enhancing its binding affinity. This finding is significant for the design of small molecule inhibitors targeting protein-protein interactions, which are implicated in numerous diseases including cancer and neurodegenerative disorders. The ability of the compound to modulate such interactions opens new avenues for the development of multitarget drugs.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)